CNS Pharmaceuticals, Inc. (CNSP)
5.75
-0.19
(-3.20%)
USD |
NASDAQ |
Sep 09, 16:00
5.75
0.00 (0.00%)
After-Hours: 17:47
CNS Pharmaceuticals Shareholders Equity (Quarterly) : 18.20M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 18.20M |
| March 31, 2026 | 0.0707M |
| December 31, 2025 | 4.523M |
| September 30, 2025 | 9.910M |
| June 30, 2025 | 13.12M |
| March 31, 2025 | 10.97M |
| December 31, 2024 | 6.177M |
| September 30, 2024 | 3.352M |
| June 30, 2024 | -4.294M |
| March 31, 2024 | -4.430M |
| December 31, 2023 | -4.432M |
| September 30, 2023 | -1.741M |
| June 30, 2023 | 2.454M |
| March 31, 2023 | 3.492M |
| December 31, 2022 | 8.133M |
| September 30, 2022 | 8.394M |
| Date | Value |
|---|---|
| June 30, 2022 | 11.52M |
| March 31, 2022 | 14.80M |
| December 31, 2021 | 6.163M |
| September 30, 2021 | 9.100M |
| June 30, 2021 | 12.41M |
| March 31, 2021 | 11.24M |
| December 31, 2020 | 13.95M |
| September 30, 2020 | 2.474M |
| June 30, 2020 | 3.725M |
| March 31, 2020 | 5.875M |
| December 31, 2019 | 7.601M |
| September 30, 2019 | 0.0002M |
| June 30, 2019 | 0.3777M |
| March 31, 2019 | -0.7168M |
| December 31, 2018 | -0.5493M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 597.21M |
| Corcept Therapeutics, Inc. | 705.78M |
| Veru, Inc. | 28.38M |
| Johnson & Johnson | 84.97B |
| Eli Lilly & Co. | 33.88B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 21.94M |
| Total Liabilities (Quarterly) | 3.738M |
| Current Ratio | 5.845 |
| Net Debt Paydown Yield | 0.60% |